Hence, it remains possible that the spatial metrics of median cancer-to-CD163+ NND or the number of adjacent CD163+ TAMs may become more important predictors than the number of communicating CD163+ cells in other solid tumors or in distinct breast cancer cohorts, for instance in different breast cancer subtypes or under different treatment. Here, CD163 is linked to breast carcinoma.